- Home
- JVA vs SNTI Comparison
JVA vs SNTI Comparison
Compare JVA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- SNTI
- Stock Information
- Founded
- JVA 1971
- SNTI 2016
- Country
- JVA United States
- SNTI United States
- Employees
- JVA N/A
- SNTI N/A
- Industry
- JVA Packaged Foods
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- SNTI Health Care
- Exchange
- JVA Nasdaq
- SNTI Nasdaq
- Market Cap
- JVA 23.8M
- SNTI 39.6M
- IPO Year
- JVA 2005
- SNTI N/A
- Fundamental
- Price
- JVA $5.09
- SNTI $1.37
- Analyst Decision
- JVA
- SNTI Strong Buy
- Analyst Count
- JVA 0
- SNTI 2
- Target Price
- JVA N/A
- SNTI $8.50
- AVG Volume (30 Days)
- JVA 81.0K
- SNTI 120.0K
- Earning Date
- JVA 09-12-2025
- SNTI 11-13-2025
- Dividend Yield
- JVA N/A
- SNTI N/A
- EPS Growth
- JVA 64.91
- SNTI N/A
- EPS
- JVA 0.32
- SNTI N/A
- Revenue
- JVA $89,748,681.00
- SNTI N/A
- Revenue This Year
- JVA N/A
- SNTI N/A
- Revenue Next Year
- JVA N/A
- SNTI $150.00
- P/E Ratio
- JVA $14.72
- SNTI N/A
- Revenue Growth
- JVA 17.92
- SNTI N/A
- 52 Week Low
- JVA $2.69
- SNTI $1.26
- 52 Week High
- JVA $9.93
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- JVA 79.45
- SNTI 37.01
- Support Level
- JVA $3.96
- SNTI $1.33
- Resistance Level
- JVA $4.16
- SNTI $1.39
- Average True Range (ATR)
- JVA 0.23
- SNTI 0.08
- MACD
- JVA 0.10
- SNTI 0.01
- Stochastic Oscillator
- JVA 68.91
- SNTI 31.43
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.